GTS-21: A Deep Dive into its Alpha7 Nicotinic Receptor Agonist Properties
NINGBO INNO PHARMCHEM CO.,LTD. is proud to highlight the advanced chemical intermediate, GTS-21 powder. This compound is distinguished by its specific interaction with the u03b17 nicotinic acetylcholine receptor (nAChR), a critical target in neurological and inflammatory pathways. As a selective u03b17 nAChR agonist, GTS-21 offers a focused approach to modulating neural activity and immune responses, making it a subject of intense scientific interest.
The u03b17 nAChR plays a vital role in brain function and the inflammatory cascade. GTS-21's ability to selectively bind to and activate these receptors means it can influence a range of physiological processes. In vitro studies have shown GTS-21 to be a potent agonist, capable of attenuating the production of pro-inflammatory cytokines. This anti-inflammatory action is significant and has led to its investigation in models of sepsis, pancreatitis, and ischemia-reperfusion injury, where inflammation plays a central role in disease progression.
Furthermore, the nootropic and neuroprotective effects associated with GTS-21 and its active metabolite, 4-OH-GTS-21, are directly linked to its interaction with the u03b17 nAChR. These effects position GTS-21 as a compound of considerable interest for treating conditions characterized by cognitive deficits and neuronal damage. The research into GTS-21 for Alzheimer's disease, nicotine dependence, and schizophrenia underscores its broad therapeutic potential in mental health and neurodegenerative disorders.
For researchers and pharmaceutical developers, sourcing high-quality GTS-21 powder is paramount. NINGBO INNO PHARMCHEM CO.,LTD. provides a reliable source to buy GTS-21 raw powder online, ensuring the purity and consistency required for advanced research. Understanding the precise mechanisms by which GTS-21 exerts its effects allows for more targeted development of therapies aimed at neurological and inflammatory conditions. The ongoing exploration of GTS-21's pharmacological profile continues to reveal its importance in modern pharmaceutical research.
Our commitment at NINGBO INNO PHARMCHEM CO.,LTD. is to facilitate groundbreaking research by supplying essential chemical intermediates like GTS-21. We empower scientists to delve deeper into the potential of selective u03b17 nAChR agonists, contributing to the development of novel treatments for a range of debilitating conditions.
Perspectives & Insights
Logic Thinker AI
“This compound is distinguished by its specific interaction with the u03b17 nicotinic acetylcholine receptor (nAChR), a critical target in neurological and inflammatory pathways.”
Molecule Spark 2025
“As a selective u03b17 nAChR agonist, GTS-21 offers a focused approach to modulating neural activity and immune responses, making it a subject of intense scientific interest.”
Alpha Pioneer 01
“The u03b17 nAChR plays a vital role in brain function and the inflammatory cascade.”